Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 4
2021 2
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors.
Schettini F, De Santo I, Rea CG, De Placido P, Formisano L, Giuliano M, Arpino G, De Laurentiis M, Puglisi F, De Placido S, Del Mastro L. Schettini F, et al. Among authors: rea cg. Front Oncol. 2018 Dec 12;8:608. doi: 10.3389/fonc.2018.00608. eCollection 2018. Front Oncol. 2018. PMID: 30631751 Free PMC article. Review.
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications.
Vernieri C, Corti F, Nichetti F, Ligorio F, Manglaviti S, Zattarin E, Rea CG, Capri G, Bianchi GV, de Braud F. Vernieri C, et al. Among authors: rea cg. Breast Cancer Res. 2020 Apr 6;22(1):33. doi: 10.1186/s13058-020-01271-0. Breast Cancer Res. 2020. PMID: 32252811 Free PMC article. Review.
Oxaliplatin in Adjuvant Colorectal Cancer: Is There a Role in Older Patients?
Dottorini L, Petrelli F, Ghidini A, Rea CG, Borgonovo K, Dognini G, Parati MC, Petrò D, Ghilardi M, Luciani A. Dottorini L, et al. Among authors: rea cg. J Clin Oncol. 2023 Jun 20;41(18):3300-3303. doi: 10.1200/JCO.23.00354. Epub 2023 May 15. J Clin Oncol. 2023. PMID: 37186881 No abstract available.
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).
Vernieri C, Nichetti F, Lalli L, Moscetti L, Giorgi CA, Griguolo G, Marra A, Randon G, Rea CG, Ligorio F, Scagnoli S, De Angelis C, Molinelli C, Fabbri A, Ferraro E, Trapani D, Milani A, Agostinetto E, Bernocchi O, Catania G, Vantaggiato A, Palleschi M, Moretti A, Basile D, Cinausero M, Ajazi A, Castagnoli L, Lo Vullo S, Gerratana L, Puglisi F, La Verde N, Arpino G, Rocca A, Ciccarese M, Pedersini R, Fabi A, Generali D, Losurdo A, Montemurro F, Curigliano G, Del Mastro L, Michelotti A, Cortesi E, Guarneri V, Pruneri G, Mariani L, de Braud F. Vernieri C, et al. Among authors: rea cg. Clin Cancer Res. 2021 Jun 15;27(12):3443-3455. doi: 10.1158/1078-0432.CCR-20-4928. Epub 2021 Mar 30. Clin Cancer Res. 2021. PMID: 33785482 Free article.
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Buono G, Crispo A, Giuliano M, De Angelis C, Schettini F, Forestieri V, Lauria R, De Laurentiis M, De Placido P, Rea CG, Pacilio C, Esposito E, Grimaldi M, Nocerino F, Porciello G, Giudice A, Amore A, Minopoli A, Botti G, De Placido S, Trivedi MV, Arpino G. Buono G, et al. Among authors: rea cg. Breast Cancer Res Treat. 2020 Jul;182(2):401-409. doi: 10.1007/s10549-020-05701-7. Epub 2020 Jun 4. Breast Cancer Res Treat. 2020. PMID: 32500397 Free PMC article.
13 results